MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and skin care market. We are developing therapies for the top 5 dermatology & skin care conditions - Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which have a huge impact on quality of life. More than 230 million patients suffer from these 5 skin diseases, which represent a $12.9 Billion Rx market and a $121 Billion skin care market.
MatriSys Bio’s scientific approach is to rebalance the natural skin microbiome by application of microbial therapies -“Good Bugs” that selectively target skin pathogens -“Bad Bugs”.
Our lead microbiome Phase I/II clinical program addresses the Atopic Dermatitis (“AD”) market with 15 M US patients (132 M worldwide), is NIH funded, and IP protected with an exclusive license from UCSD. Our “Good Bug”, S. hominis, is highly potent against the “Bad Bug”, Staph. aureus, which has long been associated with AD. S. hominis does not affect other “Good Bugs” leading to the natural rebalance of the skin microbiome.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 505 Coast Boulevard South, Suite 311, La Jolla,california 92037,united States
- Phone
- (858)456-3919
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- matrisysbio.com
- Keywords
- Skin Microbiome, Biopharmaceutical product development, Dermatology, Live Biotherapeutic Products ("LBP"), Cosmeceutics, Skin care.
- HQ
- La Jolla, California
Matrisys Bioscience, Inc. Questions
Matrisys Bioscience, Inc.'s helpline number is (858)456-3919
Matrisys Bioscience, Inc.'s website is matrisysbio.com
Matrisys Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/matrisys-bioscience-inc
Matrisys Bioscience, Inc. has
6 employees.
View email and phone details for 6
employees at Matrisys Bioscience, Inc..
Matrisys Bioscience, Inc.'s industry is
Biotechnology Research
Matrisys Bioscience, Inc.'s top competitors are
Privo Technologies Inc,
Azitra Inc,
Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt),
Concerto Biosciences,
Dermbiont, Inc.,
Amytrx Therapeutics, Inc.,
Alma Life Sciences,
Curadh Mtr Inc,
Dermaliq Therapeutics, Inc.,
Nuvig Therapeutics Inc..
Matrisys Bioscience, Inc.'s support email address is info@matrisysbio.com
Matrisys Bioscience, Inc.'s categories are Biotechnology Research
Matrisys Bioscience, Inc.'s founding year is 2015
